Amplia Therapeutics Limited (ATX.AX)
AUD 0.05
(-1.89%)
AUD 0.05
(-1.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 4.45 Million AUD | 274.34% |
| 2023 | 1.18 Million AUD | -40.03% |
| 2022 | 1.98 Million AUD | 29.33% |
| 2021 | 1.53 Million AUD | 4380.44% |
| 2020 | 34.22 Thousand AUD | -32.19% |
| 2019 | 50.47 Thousand AUD | -91.3% |
| 2018 | 580.29 Thousand AUD | -67.73% |
| 2017 | 1.79 Million AUD | -20.55% |
| 2016 | 2.26 Million AUD | 7367.47% |
| 2015 | 30.3 Thousand AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 4.45 Million AUD | 274.34% |
| 2024 Q2 | 2.44 Million AUD | 0.0% |
| 2024 Q4 | 2 Million AUD | 0.0% |
| 2023 Q4 | -579.89 Thousand AUD | 0.0% |
| 2023 FY | 1.18 Million AUD | -40.03% |
| 2023 Q2 | 1.76 Million AUD | 0.0% |
| 2022 Q4 | 1.22 Million AUD | 0.0% |
| 2022 Q2 | 762.54 Thousand AUD | 0.0% |
| 2022 FY | 1.98 Million AUD | 29.33% |
| 2021 Q4 | 673.59 Thousand AUD | 0.0% |
| 2021 FY | 1.53 Million AUD | 4380.44% |
| 2021 Q2 | 859.92 Thousand AUD | 0.0% |
| 2020 Q4 | 34.22 Thousand AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | 34.22 Thousand AUD | -32.19% |
| 2019 Q2 | 50.89 Thousand AUD | 0.0% |
| 2019 Q4 | -422.00 AUD | 0.0% |
| 2019 FY | 50.47 Thousand AUD | -91.3% |
| 2018 FY | 580.29 Thousand AUD | -67.73% |
| 2018 Q4 | -77.08 Thousand AUD | 0.0% |
| 2018 Q2 | 657.37 Thousand AUD | 0.0% |
| 2017 FY | 1.79 Million AUD | -20.55% |
| 2017 Q2 | 1.18 Million AUD | 0.0% |
| 2017 Q4 | 615.84 Thousand AUD | 0.0% |
| 2016 FY | 2.26 Million AUD | 7367.47% |
| 2016 Q4 | 1.44 Million AUD | 0.0% |
| 2016 Q2 | 816.53 Thousand AUD | 0.0% |
| 2015 Q3 | 7577.25 AUD | -48.84% |
| 2015 Q2 | 14.81 Thousand AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 FY | 30.3 Thousand AUD | 0.0% |
| 2015 Q4 | -14.81 Thousand AUD | -295.48% |
| 2014 Q3 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -156.229% |
| Acrux Limited | 5.09 Million AUD | 12.537% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -639.879% |
| BTC Health Limited | 16.36 Thousand AUD | -27117.249% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 40.293% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 61.303% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 94.95% |
| Biome Australia Limited | 13 Million AUD | 65.772% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | -27.014% |
| Memphasys Limited | 60 Thousand AUD | -7321.237% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 98.08% |
| Noxopharm Limited | 2.4 Million AUD | -85.51% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -19.944% |
| Race Oncology Limited | 4 Million AUD | -11.222% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -1388.077% |
| Starpharma Holdings Limited | 8.28 Million AUD | 46.281% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -2824.817% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | -10.784% |
| CSL Limited | 22.41 Billion AUD | 99.98% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 93.298% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -24205.36% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -4589.466% |
| Patrys Limited | 1.39 Million AUD | -219.385% |
| Orthocell Limited | 5.31 Million AUD | 16.229% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 22.05 Million AUD | 79.815% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -399.106% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -92.29% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -26092.6% |
| Nanollose Limited | 12.5 Thousand AUD | -35519.086% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -267.31% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -255.771% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.103% |
| Dimerix Limited | 583.47 Thousand AUD | -663.138% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -867.153% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -6667.085% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -840.288% |
| Actinogen Medical Limited | 9.93 Million AUD | 55.165% |
| Immuron Limited | 4.9 Million AUD | 9.181% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -71.395% |